Jiangsu Recbio Technology Co., Ltd. (2179.HK)
HKD 8.0
(-3.38%)
HKD 8.0
(-3.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -638.07 Million | -579.54 Million | -472.92 Million | -70.33 Million | -138.63 Million |
| Net Income | -572.44 Million | -735.99 Million | -657.56 Million | -179.4 Million | -138.27 Million |
| Depreciation & Amortization | 63.89 Million | 40.93 Million | 22.45 Million | 12.76 Million | 4.32 Million |
| Deferred income taxes | -16.52 Million | - | -2.7 Million | - | - |
| Stock-based compensation | 41.89 Million | 47.81 Million | 137.68 Million | - | - |
| Change in working capital | -125.36 Million | 203.27 Million | -18.74 Million | 64.31 Million | -68.21 Million |
| Other non-cash items | -29.53 Million | -135.56 Million | 45.95 Million | 31.98 Million | 63.51 Million |
| Investing Cash Flow | 9.42 Million | -378.42 Million | 68.7 Million | -258.58 Million | -345.63 Million |
| Investments in PPE | -224.11 Million | -308.49 Million | -237.86 Million | -170.73 Million | -78.96 Million |
| Acquisitions | - | - | - | - | 2.37 Million |
| Investment purchases | - | -107.46 Million | -40 Million | -145 Million | -280 Million |
| Sales/Maturities of investments | 187.95 Million | 13.55 Million | 336.21 Million | 54.51 Million | 8.76 Million |
| Other Investing Activities | 45.58 Million | 23.97 Million | 10.35 Million | 2.63 Million | 2.19 Million |
| Financing Cash Flow | 275.27 Million | 839.43 Million | 1.22 Billion | 680.38 Million | 490.17 Million |
| Debt repayment | -12.02 Million | -500 Thousand | -6.42 Million | -5.87 Million | -5.97 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -100 Million | - | - | - | - |
| Common Stock Issuance | -100 Million | 669.71 Million | - | - | - |
| Other Financing Activities | 45.6 Million | 170.22 Million | 1.23 Billion | 686.25 Million | 496.14 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | -45.62 Million | -32.61 Million | -15.78 Million | -399 Thousand | -7.01 Million |
| Other working capital | -79.73 Million | 235.88 Million | -2.96 Million | 64.71 Million | -61.19 Million |
| Cash at beginning of period | 1.16 Billion | 1.17 Billion | 355.82 Million | 7.23 Million | 1.34 Million |
| Cash at end of period | 834.98 Million | 1.16 Billion | 1.17 Billion | 355.82 Million | 7.23 Million |
| Capital Expenditure | -224.11 Million | -308.49 Million | -237.86 Million | -170.73 Million | -78.96 Million |
| Effect of forex changes on cash | 19.26 Million | 115.06 Million | -8.49 Million | -2.88 Million | - |
| Net cash flow / Change in cash | -334.1 Million | -3.47 Million | 816.74 Million | 348.58 Million | 5.89 Million |
| Free Cash Flow | -862.18 Million | -888.03 Million | -710.78 Million | -241.06 Million | -217.6 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -124.56 Million | -124.56 Million | -149.7 Million | -572.44 Million | -149.7 Million | -136.27 Million |
| Depreciation & Amortization | 19.62 Million | 19.62 Million | 17.02 Million | 63.89 Million | 14.8 Million | 15.15 Million |
| Deferred income taxes | - | - | - | -16.52 Million | - | -13.51 Million |
| Stock-based compensation | 8.88 Million | 8.88 Million | 12.49 Million | 41.89 Million | 12.49 Million | 8.45 Million |
| Change in working capital | -18.83 Million | -18.83 Million | -45.01 Million | -125.36 Million | -45.01 Million | -51.28 Million |
| Other non-cash items | -25.07 Million | -25.07 Million | 31.5 Million | -29.53 Million | 33.73 Million | -21.39 Million |
| Investing Cash Flow | -32.21 Million | -32.21 Million | 25.78 Million | 9.42 Million | 25.78 Million | -21.06 Million |
| Investments in PPE | -39.04 Million | -39.04 Million | -55.12 Million | -224.11 Million | -55.12 Million | -50.89 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 187.95 Million | - | - |
| Other Investing Activities | 6.82 Million | 6.82 Million | 80.9 Million | 45.58 Million | 80.9 Million | 29.82 Million |
| Financing Cash Flow | 17.88 Million | 17.88 Million | 53.66 Million | 275.27 Million | 53.66 Million | 83.97 Million |
| Debt repayment | - | - | - | -12.02 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -100 Million | - | -50 Million |
| Common Stock Issuance | - | - | - | -100 Million | - | - |
| Other Financing Activities | 17.88 Million | 17.88 Million | 53.66 Million | 45.6 Million | 53.66 Million | 133.97 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -27.49 Million | -27.49 Million | -27.87 Million | -45.62 Million | -27.87 Million | 5.05 Million |
| Other working capital | 8.66 Million | 8.66 Million | -17.14 Million | -79.73 Million | -17.14 Million | -56.33 Million |
| Cash at beginning of period | - | - | - | 1.16 Billion | - | - |
| Cash at end of period | -151.84 Million | -151.84 Million | -61.45 Million | 834.98 Million | -61.45 Million | -105.6 Million |
| Capital Expenditure | -39.04 Million | -39.04 Million | -55.12 Million | -224.11 Million | -55.12 Million | -50.89 Million |
| Effect of forex changes on cash | 2.46 Million | 2.46 Million | -7.2 Million | 19.26 Million | -7.2 Million | 16.83 Million |
| Net cash flow / Change in cash | -151.84 Million | -151.84 Million | -61.45 Million | -334.1 Million | -61.45 Million | -105.6 Million |
| Free Cash Flow | -179.01 Million | -179.01 Million | -188.82 Million | -862.18 Million | -188.82 Million | -236.23 Million |
CFFN
K
NXT
6275
3698
300265